MD

Mittie Doyle

DELAYED 1 MONTH

Chief Medical Officer

Avalo Therapeutics, Inc.

Filings

5

Companies

1

Latest

Jul 27, 2026

Transactions

Signal

Ticker / Company

Insider

Transaction

Value

Filed

47

Avalo Therapeutics, Inc.

Mittie Doyle

Chief Medical Officer

Sale

$20.0K

1,000 sh

Jul 29 8:05 PM

Jul 27, 2026

—

Avalo Therapeutics, Inc.

Mittie Doyle

Chief Medical Officer

Option Exercise

$12.7K

1,000 sh

Jul 29 8:05 PM

Jul 27, 2026

60
AVTXCLUSTER 4

Avalo Therapeutics, Inc.

Mittie Doyle

Chief Medical Officer

Sale

$10.9K

679 sh

Jun 1 8:05 PM

May 28, 2026

—

Avalo Therapeutics, Inc.

Mittie Doyle

Chief Medical Officer

Option Exercise

$5.5K

679 sh

Jun 1 8:05 PM

May 28, 2026

71
AVTXCLUSTER 445% OUT

Avalo Therapeutics, Inc.

Mittie Doyle

Chief Medical Officer

Sale

$56.3K

3,000 sh

May 19 8:10 PM

May 15, 2026

—

Avalo Therapeutics, Inc.

Mittie Doyle

Chief Medical Officer

Option Exercise

$38.0K

3,000 sh

May 19 8:10 PM

May 15, 2026

76
AVTXCLUSTER 297% OUT

Avalo Therapeutics, Inc.

Mittie Doyle

Chief Medical Officer

Sale

$2.2M

106,555 sh

May 7 8:16 PM

May 6, 2026

—

Avalo Therapeutics, Inc.

Mittie Doyle

Chief Medical Officer

Option Exercise

$1.2M

106,555 sh

May 7 8:16 PM

May 6, 2026

76
AVTXCLUSTER 297% OUT

Avalo Therapeutics, Inc.

Mittie Doyle

Chief Medical Officer

Sale

$26.9K

1,679 sh

May 7 8:16 PM

May 5, 2026

—

Avalo Therapeutics, Inc.

Mittie Doyle

Chief Medical Officer

Option Exercise

$18.1K

1,679 sh

May 7 8:16 PM

May 5, 2026